Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease.

Prange S, Metereau E, Maillet A, Lhommée E, Klinger H, Pelissier P, Ibarrola D, Heckemann RA, Castrioto A, Tremblay L, Sgambato V, Broussolle E, Krack P, Thobois S.

Mov Disord. 2019 Jul 15. doi: 10.1002/mds.27793. [Epub ahead of print]

PMID:
31309609
2.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig T, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Jun 18. pii: S1353-8020(19)30244-5. doi: 10.1016/j.parkreldis.2019.05.023. [Epub ahead of print]

PMID:
31257096
3.

A novel heterozygous ANO3 mutation responsible for myoclonic dystonia.

Laurencin C, Broussolle E, Danaila T, Anheim M, Chelly J, Thobois S.

J Neurol Sci. 2019 Jun 13;403:65-66. doi: 10.1016/j.jns.2019.06.014. [Epub ahead of print] No abstract available.

PMID:
31228765
4.

Structural Imaging in Parkinson's Disease: New Developments.

Prange S, Metereau E, Thobois S.

Curr Neurol Neurosci Rep. 2019 Jun 18;19(8):50. doi: 10.1007/s11910-019-0964-5. Review.

PMID:
31214847
5.

Unilateral clinical manifestations in LGI1-antibody encephalitis.

Gravier Dumonceau A, Jeannin-Mayer S, Roche P, Honnorat J, Joubert B, Thobois S, Laurencin C.

Rev Neurol (Paris). 2019 Jun 7. pii: S0035-3787(18)30801-4. doi: 10.1016/j.neurol.2018.09.022. [Epub ahead of print] No abstract available.

PMID:
31182313
6.

Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?

Mariani LL, Doulazmi M, Chaigneau V, Brefel-Courbon C, Carrière N, Danaila T, Defebvre L, Defer G, Dellapina E, Doé de Maindreville A, Geny C, Maltête D, Meissner WG, Rascol O, Thobois S, Torny F, Tranchant C, Vidailhet M, Corvol JC, Degos B; NS-Park/F-CRIN Network study group.

Parkinsonism Relat Disord. 2019 Apr 25. pii: S1353-8020(19)30207-X. doi: 10.1016/j.parkreldis.2019.04.012. [Epub ahead of print]

PMID:
31047798
7.

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

van Eimeren T, Antonini A, Berg D, Bohnen N, Ceravolo R, Drzezga A, Höglinger GU, Higuchi M, Lehericy S, Lewis S, Monchi O, Nestor P, Ondrus M, Pavese N, Peralta MC, Piccini P, Pineda-Pardo JÁ, Rektorová I, Rodríguez-Oroz M, Rominger A, Seppi K, Stoessl AJ, Tessitore A, Thobois S, Kaasinen V, Wenning G, Siebner HR, Strafella AP, Rowe JB.

Alzheimers Dement (Amst). 2019 Apr 2;11:301-309. doi: 10.1016/j.dadm.2019.01.011. eCollection 2019 Dec.

8.

[Parkinson's disease: from the description of the disease to its surgical treatment].

Broussolle E, Danaila T, Laurencin C, Polo G, Simon É, Mertens P, Thobois S.

Rev Prat. 2018 May;68(5):574-578. French. No abstract available.

PMID:
30869433
9.

[Parkinson's disease treatment: from honey moon to motor fluctuations].

Laurencin C, Danaila T, Thobois S.

Rev Prat. 2018 May;68(5):502-507. French.

PMID:
30869413
10.

Long-term effects of anterior pallidal deep brain stimulation for tourette's syndrome.

Welter ML, Houeto JL, Worbe Y, Diallo MH, Hartmann A, Tezenas du Montcel S, Ansquer S, Thobois S, Fontaine D, Rouaud T, Cuny E, Karachi C, Mallet L; STIC study group.

Mov Disord. 2019 Apr;34(4):586-588. doi: 10.1002/mds.27645. Epub 2019 Feb 20. No abstract available.

PMID:
30788865
11.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

12.

A new MRI marker of ataxia with oculomotor apraxia.

Ronsin S, Hannoun S, Thobois S, Petiot P, Vighetto A, Cotton F, Tilikete C.

Eur J Radiol. 2019 Jan;110:187-192. doi: 10.1016/j.ejrad.2018.11.035. Epub 2018 Nov 29.

13.

Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.

Girard R, Obeso I, Thobois S, Park SA, Vidal T, Favre E, Ulla M, Broussolle E, Krack P, Durif F, Dreher JC.

Brain. 2019 Jan 1;142(1):146-162. doi: 10.1093/brain/awy298.

PMID:
30590514
14.

Age and time course of long-term motor and nonmotor complications in Parkinson disease.

Prange S, Danaila T, Laurencin C, Caire C, Metereau E, Merle H, Broussolle E, Maucort-Boulch D, Thobois S.

Neurology. 2019 Jan 8;92(2):e148-e160. doi: 10.1212/WNL.0000000000006737. Epub 2018 Dec 12.

PMID:
30541866
15.

The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.

Schmitt E, Krack P, Castrioto A, Klinger H, Bichon A, Lhommée E, Pelissier P, Fraix V, Thobois S, Moro E, Martinez-Martin P.

Mov Disord Clin Pract. 2018 Mar 23;5(3):265-272. doi: 10.1002/mdc3.12607. eCollection 2018 May-Jun.

16.

Molecular Imaging of Opioid System in Idiopathic Parkinson's Disease.

Thobois S, Brefel-Courbon C, Le Bars D, Sgambato-Faure V.

Int Rev Neurobiol. 2018;141:275-303. doi: 10.1016/bs.irn.2018.07.029. Epub 2018 Aug 13. Review.

PMID:
30314599
17.

What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective.

Thobois S, Prange S, Scheiber C, Broussolle E.

Parkinsonism Relat Disord. 2019 Feb;59:93-100. doi: 10.1016/j.parkreldis.2018.08.016. Epub 2018 Aug 30.

PMID:
30181086
18.

Removing deep brain stimulation artifacts from the electroencephalogram: Issues, recommendations and an open-source toolbox.

Lio G, Thobois S, Ballanger B, Lau B, Boulinguez P.

Clin Neurophysiol. 2018 Oct;129(10):2170-2185. doi: 10.1016/j.clinph.2018.07.023. Epub 2018 Aug 13. Review.

PMID:
30144660
19.

Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates.

Beaudoin-Gobert M, Météreau E, Duperrier S, Thobois S, Tremblay L, Sgambato V.

Neuroimage. 2018 Dec;183:132-141. doi: 10.1016/j.neuroimage.2018.08.016. Epub 2018 Aug 10.

PMID:
30102999
20.

Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy.

Lopez-Cuina M, Fernagut PO, Canron MH, Vital A, Lannes B, De Paula AM, Streichenberger N, Guehl D, Damier P, Eusebio A, Houeto JL, Tison F, Tranchant C, Viallet F, Witjas T, Thobois S, Meissner WG.

Neurobiol Dis. 2018 Oct;118:155-160. doi: 10.1016/j.nbd.2018.07.016. Epub 2018 Jul 17.

PMID:
30026036
21.

Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation.

Laurencin C, Montaut S, Vial C, Bernard L, Bin S, Rascle L, Polo G, Mertens P, Danaila T, Thobois S.

J Neurol Sci. 2018 Sep 15;392:65-68. doi: 10.1016/j.jns.2018.07.004. Epub 2018 Jul 12.

PMID:
30025235
22.

Clonidine modulates the activity of the subthalamic-supplementary motor loop: evidence from a pharmacological study combining deep brain stimulation and electroencephalography recordings in Parkinsonian patients.

Spay C, Albares M, Lio G, Thobois S, Broussolle E, Lau B, Ballanger B, Boulinguez P.

J Neurochem. 2018 Aug;146(3):333-347. doi: 10.1111/jnc.14447.

PMID:
29675956
23.

Novel XK mutation in a McLeod patient diagnosed after heart transplant.

Laurencin C, Sebbag L, Jousserand G, Demontes M, Campean L, Thivolet-Bejui F, Lebre AS, Thobois S.

Clin Neurol Neurosurg. 2018 May;168:64-66. doi: 10.1016/j.clineuro.2018.02.039. Epub 2018 Mar 1. No abstract available.

PMID:
29524658
24.

Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes.

Coutelier M, Hammer MB, Stevanin G, Monin ML, Davoine CS, Mochel F, Labauge P, Ewenczyk C, Ding J, Gibbs JR, Hannequin D, Melki J, Toutain A, Laugel V, Forlani S, Charles P, Broussolle E, Thobois S, Afenjar A, Anheim M, Calvas P, Castelnovo G, de Broucker T, Vidailhet M, Moulignier A, Ghnassia RT, Tallaksen C, Mignot C, Goizet C, Le Ber I, Ollagnon-Roman E, Pouget J, Brice A, Singleton A, Durr A; Spastic Paraplegia and Ataxia Network.

JAMA Neurol. 2018 May 1;75(5):591-599. doi: 10.1001/jamaneurol.2017.5121.

25.

Deep brain stimulation as a therapeutic option for obesity: A critical review.

Bétry C, Thobois S, Laville M, Disse E.

Obes Res Clin Pract. 2018 May - Jun;12(3):260-269. doi: 10.1016/j.orcp.2018.02.004. Epub 2018 Feb 21. Review.

PMID:
29475604
26.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
27.

Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.

Abbes M, Lhommée E, Thobois S, Klinger H, Schmitt E, Bichon A, Castrioto A, Xie J, Fraix V, Kistner A, Pélissier P, Seigneuret É, Chabardès S, Mertens P, Broussolle E, Moro E, Krack P.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):836-843. doi: 10.1136/jnnp-2017-316373. Epub 2018 Feb 7.

PMID:
29436490
28.

Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.

Renaud M, Moreira MC, Ben Monga B, Rodriguez D, Debs R, Charles P, Chaouch M, Ferrat F, Laurencin C, Vercueil L, Mallaret M, M'Zahem A, Pacha LA, Tazir M, Tilikete C, Ollagnon E, Ochsner F, Kuntzer T, Jung HH, Beis JM, Netter JC, Djamshidian A, Bower M, Bottani A, Walsh R, Murphy S, Reiley T, Bieth É, Roelens F, Poll-The BT, Lourenço CM, Jardim LB, Straussberg R, Landrieu P, Roze E, Thobois S, Pouget J, Guissart C, Goizet C, Dürr A, Tranchant C, Koenig M, Anheim M.

JAMA Neurol. 2018 Apr 1;75(4):495-502. doi: 10.1001/jamaneurol.2017.4373.

29.

Historical crossroads in the conceptual delineation of apathy in Parkinson's disease.

Prange S, Pagonabarraga J, Krack P, Kulisevsky J, Sgambato V, Tremblay L, Thobois S, Broussolle E.

Brain. 2018 Feb 1;141(2):613-619. doi: 10.1093/brain/awx362. No abstract available.

PMID:
29329378
30.

Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.

Météreau E, Beaudoin-Gobert M, Duperrier S, Thobois S, Tremblay L, Sgambato-Faure V.

Mov Disord. 2018 Feb;33(2):298-309. doi: 10.1002/mds.27201. Epub 2017 Oct 27.

PMID:
29076602
31.

Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.

Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E.

Curr Neurol Neurosci Rep. 2017 Aug 18;17(10):76. doi: 10.1007/s11910-017-0788-0. Review.

PMID:
28822071
32.

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

Delpont B, Lhommée E, Klinger H, Schmitt E, Bichon A, Fraix V, Castrioto A, Quesada JL, Pélissier P, Kistner A, Carnicella S, Lüscher C, Broussolle E, Pollak P, Thobois S, Krack P.

Mov Disord. 2017 Nov;32(11):1566-1573. doi: 10.1002/mds.27101. Epub 2017 Jul 24.

PMID:
28737225
33.

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial.

Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, Hartmann A, Czernecki V, Bardinet E, Yelnik J, du Montcel ST, Agid Y, Vidailhet M, Cornu P, Tanguy A, Ansquer S, Jaafari N, Poulet E, Serra G, Burbaud P, Cuny E, Aouizerate B, Pollak P, Chabardes S, Polosan M, Borg M, Fontaine D, Giordana B, Raoul S, Rouaud T, Sauvaget A, Jalenques I, Karachi C, Mallet L; STIC study group.

Lancet Neurol. 2017 Aug;16(8):610-619. doi: 10.1016/S1474-4422(17)30160-6. Epub 2017 Jun 20.

PMID:
28645853
34.

Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.

Lhommée E, Boyer F, Wack M, Pélissier P, Klinger H, Schmitt E, Bichon A, Fraix V, Chabardès S, Mertens P, Castrioto A, Kistner A, Broussolle E, Thobois S, Krack P.

Mov Disord. 2017 Aug;32(8):1191-1200. doi: 10.1002/mds.27065. Epub 2017 Jun 23.

PMID:
28643887
35.

Optimizing the deep brain stimulation care pathway in patients with Parkinson's disease.

Thomas NJ, Mertens P, Danaila T, Polo G, Klinger H, Broussolle E, Thobois S.

J Neurol. 2017 Jul;264(7):1454-1464. doi: 10.1007/s00415-017-8548-2. Epub 2017 Jun 19.

PMID:
28631129
36.

Amyotrophic lateral sclerosis in Huntington disease gene carrier.

Bernard E, Mouzat K, Leblanc P, Bost M, Lumbroso S, Thobois S, Broussolle E.

Rev Neurol (Paris). 2017 Dec;173(10):670-671. doi: 10.1016/j.neurol.2017.05.005. Epub 2017 Jun 7. No abstract available.

PMID:
28595974
37.

Evidence for dopaminergic denervation in classical galactosemia.

Poisson A, Roze E, Demily C, Thobois S.

Mov Disord. 2017 Jun;32(6):940-942. doi: 10.1002/mds.26980. Epub 2017 Apr 3. No abstract available.

PMID:
28370299
38.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group.

Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Review.

39.

Imagerie cérébrale dans les syndromes parkinsoniens.

Prange S, Hermier M, Danaila T, Laurencin C, Thobois S.

Presse Med. 2017 Mar;46(2 Pt 1):202-209. doi: 10.1016/j.lpm.2016.09.025. Epub 2016 Dec 28. French.

PMID:
28040345
40.

Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients.

Laurencin C, Brunet AS, Dumortier J, Lion-Francois L, Thobois S, Mabrut JY, Dubois R, Woimant F, Poujois A, Guillaud O, Lachaux A, Broussolle E.

Eur Neurol. 2017;77(1-2):5-15. doi: 10.1159/000452658. Epub 2016 Nov 19.

PMID:
27866189
41.

Subthalamic nucleus stimulation effects on single and combined task performance in Parkinson's disease patients: a PET study.

Atkinson-Clement C, Maillet A, LeBars D, Lavenne F, Redouté J, Krainik A, Pollak P, Thobois S, Pinto S.

Brain Imaging Behav. 2017 Aug;11(4):1139-1153. doi: 10.1007/s11682-016-9588-4.

PMID:
27704407
42.

High incidence of carpal tunnel syndrome after deep brain stimulation in Parkinson's disease.

Loizon M, Laurencin C, Vial C, Danaila T, Thobois S.

J Neurol. 2016 Dec;263(12):2416-2418. Epub 2016 Sep 13.

PMID:
27624119
43.

The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.

Maillet A, Krack P, Lhommée E, Météreau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S.

Brain. 2016 Sep;139(Pt 9):2486-502. doi: 10.1093/brain/aww162. Epub 2016 Aug 17.

PMID:
27538418
44.

Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited.

Laurencin C, Danaila T, Broussolle E, Thobois S.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):512-523. doi: 10.1016/j.neurol.2016.07.007. Epub 2016 Jul 29. Review.

PMID:
27476416
45.

A rare case of SPG11 mutation with multiple sclerosis.

Laurencin C, Rascle L, Cotton F, Grosset-Janin C, Bernard E, Depienne C, Vukusic S, Thobois S.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):389-91. doi: 10.1016/j.neurol.2016.03.006. Epub 2016 May 11.

PMID:
27180005
46.

Slowness in Movement Initiation is Associated with Proactive Inhibitory Network Dysfunction in Parkinson's Disease.

Criaud M, Poisson A, Thobois S, Metereau E, Redouté J, Ibarrola D, Baraduc P, Broussolle E, Strafella AP, Ballanger B, Boulinguez P.

J Parkinsons Dis. 2016 Apr 2;6(2):433-40. doi: 10.3233/JPD-150750.

PMID:
27061065
47.

A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia.

Hainque E, Vidailhet M, Cozic N, Charbonnier-Beaupel F, Thobois S, Tranchant C, Brochard V, Glibert G, Drapier S, Mutez E, Doe De Maindreville A, Lebouvier T, Hubsch C, Degos B, Bonnet C, Grabli D, Legrand AP, Méneret A, Azulay JP, Bissery A, Zahr N, Clot F, Mallet A, Dupont S, Apartis E, Corvol JC, Roze E.

Neurology. 2016 May 3;86(18):1729-35. doi: 10.1212/WNL.0000000000002631. Epub 2016 Apr 6.

PMID:
27053715
48.

Emotional manifestations of PD: Neurobiological basis.

Castrioto A, Thobois S, Carnicella S, Maillet A, Krack P.

Mov Disord. 2016 Aug;31(8):1103-13. doi: 10.1002/mds.26587. Epub 2016 Apr 4. Review.

PMID:
27041545
49.

Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.

Ballanger B, Beaudoin-Gobert M, Neumane S, Epinat J, Metereau E, Duperrier S, Broussolle E, Thobois S, Bonnefoi F, Tourvielle C, Lavenne F, Costes N, Lebars D, Zimmer L, Sgambato-Faure V, Tremblay L.

J Neurosci. 2016 Feb 3;36(5):1577-89. doi: 10.1523/JNEUROSCI.2010-15.2016.

50.

Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia.

Pouclet-Courtemanche H, Rouaud T, Thobois S, Nguyen JM, Brefel-Courbon C, Chereau I, Cuny E, Derost P, Eusebio A, Guehl D, Laurencin C, Mertens P, Ory-Magne F, Raoul S, Regis J, Ulla M, Witjas T, Burbaud P, Rascol O, Damier P.

Neurology. 2016 Feb 16;86(7):651-9. doi: 10.1212/WNL.0000000000002370. Epub 2016 Jan 20.

PMID:
26791148

Supplemental Content

Loading ...
Support Center